Company Overview - Deloitte LLP is planning to cut jobs in its UK business due to a sector-wide slowdown in consulting services [1] - The company is reviewing its internal services teams, with potential job eliminations in marketing and business development roles [1] Financial Performance - Deloitte's revenue for its tech consulting business decreased by 10% to £1.67 billion in 2025, attributed to clients reducing spending [6] - Overall revenue fell by 1% to £5.68 billion, down from £5.75 billion the previous year [6] - The audit and assurance business grew by 3% to £969 million, while the tax and legal unit increased by 7% to £1.34 billion [6] - The strategy, risk, and transactions business also saw a 3% increase to £901 million [6] Compensation and Employment Changes - Deloitte partners in the UK and Switzerland received an average pay raise of 4% for the financial year ending May 31, with pay rising to approximately £1.05 million from £1.01 million [2] - In contrast, rival PricewaterhouseCoopers maintained its UK partners' pay at an average of £865,000 [2] Industry Context - The consulting industry is facing a decline in demand for traditional services, exacerbated by a decrease in mergers and acquisitions and government spending cuts in the US [3] - Other firms in the industry, such as Accenture Plc and McKinsey & Co., have also reduced headcounts in response to the challenging market conditions [3] Strategic Response - Deloitte may eliminate some roles but is also considering creating new positions and relocating at-risk staff where feasible [4] - The firm underwent a major reorganization in 2024, reducing its business units from five to four [4] - Deloitte's UK senior partner noted that geopolitical and economic challenges have led clients to delay investments [4][5] - The company aims to continue transforming its operations through technology adoption and enhanced collaboration with other Deloitte member firms [5]

Core Points - Cordoba Minerals Corp. held its Annual General Meeting of Shareholders on June 9, 2025, where all nominated directors were elected [1] - Shareholders voted overwhelmingly in favor of the re-appointment of Deloitte LLP as the company's auditors for the upcoming year [2] - The company's stock option plan was re-approved, allowing for the issuance of shares not exceeding 10% of the company's issued and outstanding shares, pending final approval from the TSX Venture Exchange [3] Company Overview - Cordoba Minerals Corp. is focused on the exploration, development, and acquisition of copper and gold projects, including the Alacran Project in Colombia and a 51% interest in the Perseverance Copper Project in Arizona, USA [4]

Core Insights - Nxera Pharma has appointed Mr. Kiyoshi Kaneko as Chief Commercial Officer and promoted Ms. Mariko Nakafuji to Chief Legal Officer, effective April 1, 2025 [1][4] Group 1: Leadership Appointments - Mr. Kiyoshi Kaneko brings extensive experience in business development and corporate strategy from his previous roles at AstraZeneca and Luye Life Sciences Group Japan [2] - Ms. Mariko Nakafuji, who joined Nxera in 2021, played a significant role in the acquisition of Idorsia Pharmaceuticals' Japan and South Korean businesses and has a background in corporate M&A and private equity [3] Group 2: Company Strategy and Vision - The appointments are aimed at enhancing Nxera's commercial activities in Japan and positioning the company as a leading biopharma business in the region [4][5] - Mr. Kaneko expressed confidence in Nxera's ability to capitalize on opportunities in the Japanese pharmaceutical industry, emphasizing the company's focus on commercialization capabilities [5] Group 3: Company Overview - Nxera Pharma is a technology-powered biopharma company focused on developing specialty medicines for unmet patient needs in Japan and globally [6] - The company has over 30 active programs in its pipeline, targeting areas such as neurology, gastrointestinal disorders, immunology, metabolic disorders, and rare diseases [7] - Nxera employs over 350 people across key locations including Tokyo, Osaka, London, Cambridge, Basel, and Seoul, and is listed on the Tokyo Stock Exchange [8]